Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-24 Option Award | 2023-02-28 5:55 pm | N/A 2033-02-24 | Oncocyte Corp | OCX | John Anish M. Chief Financial Officer | 121,381 | $0 | 121,381 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:14 pm | N/A 2033-01-17 | Oncocyte Corp | OCX | John Anish M. Chief Financial Officer | 250,466 | $0 | 250,466 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:19 pm | N/A 2032-08-15 | Oncocyte Corp | OCX | John Anish M. Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-15 7:49 pm | N/A 2022-06-01 | Oncocyte Corp | OCX | John Anish M. SVP, Finance, and Interim CFO | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2022-06-13 5:50 pm | N/A 2031-09-13 | Oncocyte Corp | OCX | John Anish M. SVP, Finance, and Interim CFO | 0 | $0 | 200,000 (Direct) | View |